{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:03:46Z","timestamp":1759961026666},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Tsumura & Co."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2227-6","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T11:28:22Z","timestamp":1508326102000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Takuya","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Owada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuro","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Osugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunori","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Shio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yokouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Ohbuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"issue":"4","key":"2227_CR1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10147-011-0289-0","volume":"17","author":"Y Hiura","year":"2012","unstructured":"Hiura Y, Takiguchi S, Yamamoto K, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, Doki Y. Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol. 2012;17(4):316\u201323.","journal-title":"Int J Clin Oncol"},{"key":"2227_CR2","unstructured":"NCCN. NCCN clinical practice guidelines in oncology: Antiemesis V.2.2016. 2016. \nhttp:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf\n\n."},{"issue":"4","key":"2227_CR3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1200\/JCO.2015.64.3635","volume":"34","author":"PJ Hesketh","year":"2016","unstructured":"Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, Danso MA, Jordan K, Somerfield MR, Kris MG, et al. Antiemetics: American Society of Clinical Oncology Focused Guideline Update. J Clin Oncol. 2016;34(4):381\u20136.","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"2227_CR4","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol. 2010;21 Suppl 5:v232\u201343.","journal-title":"Ann Oncol"},{"key":"2227_CR5","unstructured":"Japan Society of Clinical Oncology. Guideline: appropriate use of antiemetic drugs, Version 1. Tokyo: Kanehara; 2010."},{"issue":"5","key":"2227_CR6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T, Nakanishi Y, Kamura T, Baba H, Yoshida K, Yamamoto N, Kitagawa Y, Maehara Y, et al. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol. 2015;20(5):855\u201365.","journal-title":"Int J Clin Oncol"},{"issue":"22","key":"2227_CR7","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","volume":"21","author":"PJ Hesketh","year":"2003","unstructured":"Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R, Chawla SP, Carides AD, Ianus J, Elmer ME, et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin\u2014the Aprepitant Protocol 052 Study Group. J Clin Oncol. 2003;21(22):4112\u20139.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2227_CR8","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2008.02.078","volume":"134","author":"H Takeda","year":"2008","unstructured":"Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, Asaka M. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134(7):2004\u201313.","journal-title":"Gastroenterology"},{"issue":"2","key":"2227_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3937\/kampomed.43.255","volume":"43","author":"H Murakuni","year":"1992","unstructured":"Murakuni H, Ozawa T, Seimiya S, Tsugu Y. Effect of Rikkunshi-to for interdigestive migrating complex in dogs. Kampo Medicine. 1992;43(2):255\u201362.","journal-title":"Kampo Medicine"},{"issue":"5","key":"2227_CR10","first-page":"211","volume":"25","author":"T Hayakawa","year":"1999","unstructured":"Hayakawa T, Arakawa T, Kase Y, Akiyama S, Ishige A, Takeda S, Sasaki H, Uno H, Fukuda T, Higuchi K, Kobayashi K. Liu-Jun-Zi-Tang, a Kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res. 1999;25(5):211\u20138.","journal-title":"Drugs Exp Clin Res"},{"issue":"6","key":"2227_CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1267\/ahc.28.539","volume":"28","author":"XM Yu","year":"1995","unstructured":"Yu XM, Liu YZ, Noda T, Ogawa K. Chinese traditional medicine protects gastric parietal cells from adriamycin cytotoxicity. Acta Histochem Cytochem. 1995;28(6):539\u201347.","journal-title":"Acta Histochem Cytochem"},{"issue":"1","key":"2227_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1210\/en.2009-0633","volume":"151","author":"H Takeda","year":"2010","unstructured":"Takeda H, Muto S, Hattori T, Sadakane C, Tsuchiya K, Katsurada T, Ohkawara T, Oridate N, Asaka M. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology. 2010;151(1):244\u201352.","journal-title":"Endocrinology"},{"issue":"7","key":"2227_CR13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/nmo.12348","volume":"26","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Matsuzaki J, Fukushima Y, Suzaki F, Kasugai K, Nishizawa T, Naito Y, Hayakawa T, Kamiya T, Andoh T, Yoshida H, Tokura Y, Nagata H, Kobayakawa M, Mori M, Kato K, Hosoda H, Takebayashi T, Miura S, Uemura N, Joh T, Hibi T, Tack J. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia\u2014a multicenter, double-blind, randomized, journal of the European Gastrointestinal Motility Society. Neurogastroenterol Motil. 2014;26(7):950\u201361.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"2227_CR14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00535-011-0488-5","volume":"47","author":"K Tominaga","year":"2012","unstructured":"Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, Umegaki E, Higuchi K, Kusano M, Arakawa T. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol. 2012;47(3):284\u201392.","journal-title":"J Gastroenterol"},{"key":"2227_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CEG.S26297","volume":"4","author":"T Ohno","year":"2011","unstructured":"Ohno T, Yanai M, Ando H, Toyomasu Y, Ogawa A, Morita H, Ogata K, Mochiki E, Asao T, Kuwano H. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans. Clin Exp Gastroenterol. 2011;4:291\u20136.","journal-title":"Clin Exp Gastroenterol"},{"key":"2227_CR16","unstructured":"MASCC Antiemesis Tool (MAT). \nhttp:\/\/www.mascc.org\/MAT\n\n. Accessed 15 Dec 2014."},{"key":"2227_CR17","unstructured":"Statistical principles for clinical trials. \nhttps:\/\/www.pmda.go.jp\/int-activities\/int-harmony\/ich\/0031.html\n\n. Accessed 15 Dec 2014."},{"key":"2227_CR18","unstructured":"Structure and content of clinical study reports. \nhttps:\/\/www.pmda.go.jp\/int-activities\/int-harmony\/ich\/0025.html\n\n. Accessed 15 Dec 2014."},{"issue":"5","key":"2227_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2227_CR20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/07853890109002086","volume":"33","author":"H Sintonen","year":"2001","unstructured":"Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328\u201336.","journal-title":"Ann Med"},{"issue":"10","key":"2227_CR21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashlet S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O\u2019Brien ME. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004;90(10):1905\u201311.","journal-title":"Br J Cancer"},{"key":"2227_CR22","first-page":"415450","volume":"2013","author":"M Tomoaki","year":"2013","unstructured":"Tomoaki M, Makoto A, Masaharu Y, Kentaro S, Kazuyoshi N, Tatsuro K, Fumihiko K, Taketo Y, Osamu Y. Changes in plasma ghrelin and serum leptin levels after cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma. ISRN Gastroenterol. 2013;2013:415450.","journal-title":"ISRN Gastroenterol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T11:28:36Z","timestamp":1508326116000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2227-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2227-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]},"article-number":"485"}}